BRIEF published on 06/18/2026 at 09:35, 25 days 20 hours ago AATec Medical dévoilera les données de l'ATL-105 lors de sa conférence de 2026. ATL-105 Données Précliniques Bronchectasie Traitement Multimodal Essai De Phase 1/2
BRIEF published on 06/18/2026 at 09:35, 25 days 20 hours ago AATec Medical to Unveil ATL-105 Data at 2026 Conference Preclinical Data ATL-105 Phase 1/2 Trial Bronchiectasis Multimodal Treatment
PRESS RELEASE published on 06/18/2026 at 09:30, 25 days 20 hours ago AATec to Present Data from Lead Candidate ATL-105 at World Bronchiectasis Conference 2026 AATec to present preclinical data on lead candidate ATL-105 at World Bronchiectasis Conference 2026, demonstrating multimodal effects for non-CF bronchiectasis treatment Respiratory Diseases Preclinical Data ATL-105 Bronchiectasis AATec
BRIEF published on 07/15/2025 at 09:05, 11 months 29 days ago AATec Medical et Northway Biotech forment un partenariat pour le développement de la production d'ATL-105 Partenariat ATL-105 Fabrication De Produits Biologiques Maladies Pulmonaires Thérapie Respiratoire
BRIEF published on 07/15/2025 at 09:05, 11 months 29 days ago AATec Medical and Northway Biotech Form Partnership for ATL-105 Production Development Partnership ATL-105 Biologics Manufacturing Lung Diseases Respiratory Therapy
PRESS RELEASE published on 07/15/2025 at 09:00, 11 months 29 days ago AATec Medical and Northway Biotech Announce Partnership to Develop Industrial Production Process for ATL-105 Targeting Lung Diseases AATec Medical and Northway Biotech announce partnership to develop industrial production process for ATL-105 targeting lung diseases Partnership AATec Medical ATL-105 Lung Diseases Northway Biotech
BRIEF published on 04/15/2025 at 11:09, 1 year 2 months ago AATec Medical Secures EUR 4 Million for Respiratory Drug Development Biotechnology Funding Clinical Trials Drug Development Respiratory Diseases
BRIEF published on 04/15/2025 at 11:09, 1 year 2 months ago AATec Medical obtient 4 millions d'euros pour le développement de médicaments respiratoires Biotechnologie Financement Essais Cliniques Développement De Médicaments Maladies Respiratoires
PRESS RELEASE published on 04/15/2025 at 11:04, 1 year 2 months ago AATec Medical Secures EUR 4 Million to Advance Lead Respiratory Drug Candidate to Clinical Development AATec Medical secures EUR 4 million funding to advance lead respiratory drug candidate, ATL-105, for clinical development to treat non-CF bronchiectasis by 2026 Clinical Development AATec Medical Non-CF Bronchiectasis EUR 4 Million Respiratory Drug Candidate
BRIEF published on 09/18/2024 at 10:05, 1 year 9 months ago AATec Medical accueille le professeur James Chalmers au sein de son conseil consultatif scientifique AATec Medical Conseil Consultatif Scientifique James Chalmers Bronchectasie AAT Recombinante
Published on 07/14/2026 at 01:45, 3 hours 55 minutes ago Arctic Fox Lithium Approved for Trading on the OTCQB Venture Market and Announces DTC Eligibility
Published on 07/14/2026 at 00:01, 5 hours 39 minutes ago Captor Capital Announces Delay in its Annual Filings
Published on 07/13/2026 at 23:10, 6 hours 30 minutes ago Galaxy Ventures Inc. Announces Director Resignation
Published on 07/13/2026 at 21:35, 8 hours 5 minutes ago ATHA Energy Announces Corporate Activities Update
Published on 07/13/2026 at 20:00, 9 hours 40 minutes ago IBC Announces Share-Based Compensation to Directors
Published on 07/14/2026 at 04:45, 54 minutes ago Asia’s Debut of LEAP East in HKCEC Marks Hong Kong’s Largest Inaugural Tech Summit
Published on 07/13/2026 at 22:30, 7 hours 9 minutes ago Half-year 2026 Results Media and Investor Conference Call and Webcast
Published on 07/13/2026 at 21:20, 8 hours 19 minutes ago Evotec Announces Preliminary Second Quarter and First Half 2026 Results and Updates Full-Year 2026 Outlook
Published on 07/13/2026 at 21:17, 8 hours 22 minutes ago EQS-Adhoc: Ad hoc: Evotec Announces Preliminary Second Quarter and First Half 2026 Results and Updates Full-Year 2026 Outlook
Published on 07/13/2026 at 20:48, 8 hours 51 minutes ago EQS-Adhoc: Gateway Real Estate AG: Forecast for the financial year 2026
Published on 07/13/2026 at 18:00, 11 hours 40 minutes ago CP Icade - Icade reprend 100% de la propriété de la Tour Eqho à la Défense
Published on 07/13/2026 at 18:00, 11 hours 40 minutes ago PR Icade - Icade regains full ownership of the Eqho Tower in La Défense
Published on 07/13/2026 at 18:00, 11 hours 40 minutes ago THERMADOR GROUPE : publication du chiffre d'affaires semestriel 2026
